title: Current Guidance for Brca Mutation Testing in Ovarian Cancer Patients.
authors.affiliation: IMS Health Germany, Munich, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Ehlken
authors.affiliation: IMS Health, Munich, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Driedger
authors.affiliation: IMS Health Germany, Munich, Germany.
authors.forename: L
authors.initials: L
authors.lastname: Hofmann-Xu
authors.affiliation: IMS Health, Munich, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Paulus
authors.affiliation: IMS Health Germany, Munich, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Berger
authors.affiliation: IMS Health US, Alexandria, VA, USA.
authors.forename: C
authors.initials: C
authors.lastname: de Moor
authors.affiliation: IMS Health Germany, Munich, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Schroeder
authors.affiliation: AstraZeneca, London, UK.
authors.forename: J
authors.initials: J
authors.lastname: Clune
authors.affiliation: AstraZeneca, Gaithersburg, MD, USA.
authors.forename: J
authors.initials: J
authors.lastname: Tyczynski